Reported adverse effects of SGLT-2 inhibitors included urinary tract infection (43.8%), small ulcers in lower extremities (10%), cellulitis (10%), AKI (3.6%), and genital fungal infection (1.4%), respectively. The gene discussed is SLC5A2; the disease is cellulitis.